Thanks to his extensive experience working in the medical device, vaccine and pharma industry, Conrod Kelly was chosen by Merck to serve as its first executive director, social determinants and population health. Before that, he served as the company’s executive director of its U.S. diabetes franchise. In the position, he spearheaded sales and share growth of the diabetes medication Januvia, and was instrumental in accelerating the launch of Steglatro.

Kelly’s recognition of the importance of social determinants of health and the role of cultural relevance in diabetes management played a significant role in both initiatives. Along these same lines, he worked on A Touch of Sugar, a film made to raise awareness of the social factors that contribute to the diabetes epidemic in the U.S. He was also the driving force behind the creation of a new content marketing platform, which focuses on culturally relevant information to support behavior change.  

Before leading Merck’s diabetes portfolio, Kelly was the U.S. marketing lead for the company’s Bridion, Entereg and Alzheimer’s franchises. Prior to that, he held a series of other internal positions, including Merck’s U.S. scientific strategy lead and a global marketing manager at the company. 

Before joining Merck in 2009, Kelly worked at LifeScan, a Johnson & Johnson company, in strategic customer marketing, and at GlaxoSmithKline in vaccines sales and marketing.